1. Olson, S.: Biotechnology, An Industry Comes of Age, National Academy Press, Washington, D. C., 1986.
2. Office of Science and Technology Policy. Proposal for a coordinated framework for regulation of biotechnology. Fed. Reg. 49: 50856–50907, 1984.
3. Waffe, S. O., and Lasagna, L.: From DNA to NDA—The impact of recombinant DNA technology on new drug development. Regul. Toxicol. Pharmacol. 5: 212–224, 1985.
4. Reedijk, J., and Lohman, P. H. M.: Cis-platinum; synthesis, antitumor activity and mechanisms of action. Pharm. Weekbl. (Sci.)
7 (5): 173–180, 1985.
5. Strudenski, A. B., Conner, B. J., Impraim, C. C., Teplitz, R. L., and Wallace, R. B.: Discrimination among the human ß^, ßs, ßC-globin genes using allele-specific oligonucleotide hybridization probes. Am. J. Hum. Genet. 37: 42–51, 1985.